7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/15/2013

Company Name Symbol %Change
A M R CP AAMRQ
8.29%
KRATOS DEFEN KTOS
6.03%
NOAH HOLDING NOAH
5.24%
AETERNA ZENT AEZS
3.67%
QIHOO 360 TE QIHU
3.22%

Roper Expands in Medical Segment

by Zacks Equity Research

April 19, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Roper Industries Inc. ( ROP - Snapshot Report ) has agreed to a buy Managed Health Care Associates, Inc. (“MHA”) for an all-cash deal of $1 billion. The company expects to close the acquisition in the next 30 days, subject to the required regulatory approvals.

Managed Health Care Associates, based in Florham Park, N.J, provides healthcare services and solutions like Group Purchasing, Managed Care and Payer Contracting, Pharmaceutical Data Analytics and Clinical Services. MHA’s services and software enhances business growth through operational efficiency for its clients.

Roper projects that the current acquisition will generate approximately $95.0 million in EBITDA for the first 12 months. This excludes acquisition-related fair value accounting. The recent acquisitions reflect Roper’s focus on expanding its high-margin businesses. Given MHA’s significant growth opportunities, recurring revenue stream and strong cash flow generation, we believe that the acquisition will be accretive for Roper over the long term.

Acquisitions have been an integral part of Roper’s growth story and had resulted in incremental revenues. Roper’s last acquisition in the medical segment was Sunquest Information Systems Inc. for $1.4 billion in mid-2012. Roper’s revenues from Medical & Scientific Imaging segment had increased 15.3% year over year in fiscal 2012 while its orders increased 14.7% in fiscal 2012.

We believe that strong backlog coupled with robust organic growth will drive earnings growth going forward. Moreover, accretive acquisitions will expand its product portfolio, providing a significant competitive edge over its peers.

However, macroeconomic concerns, integration issues due to acquisitions and competition from Agilent Technologies Inc. ( A - Analyst Report ) , Halliburton Company ( HAL - Analyst Report ) and IDEX Corp ( IEX - Snapshot Report ) are possible headwinds for the company.

Currently, Roper has a Zacks Rank #2 (Buy).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.